Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database

Statin therapy prevents the onset of Parkinson disease in patients with diabetes

(2016) Kun-Der Lin et al.   ANNALS OF NEUROLOGY

Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis

(2016) Katsiaryna Bykov et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

(2015) Xuemei Huang et al.   MOVEMENT DISORDERS

APOE and LRPAP1 gene polymorphism and risk of Parkinson’s disease

(2014) Neeraj Kumar Singh et al.   NEUROLOGICAL SCIENCES

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Holding on to statins in Parkinson disease

(2013) E.-K. Tan et al.   NEUROLOGY

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

(2013) B. Mollenhauer et al.   NEUROLOGY

Discontinuation of statin therapy associates with Parkinson disease: A population-based study

(2013) Y.-C. Lee et al.   NEUROLOGY

Prospective Study of Statin Use and Risk of Parkinson Disease

(2012) Xiang Gao   ARCHIVES OF NEUROLOGY

Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms

(2012) Anil Kumar et al.   BRAIN RESEARCH

Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies

(2012) Krishna Undela et al.   JOURNAL OF NEUROLOGY

Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses

(2011) Junqiang Yan et al.   PLoS One

Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan

(2010) Yoshihiro Miyake et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Statin use and Parkinson's disease in Denmark

(2010) Beate Ritz et al.   MOVEMENT DISORDERS

Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies

(2009) Andrew O. Koob et al.   EXPERIMENTAL NEUROLOGY

Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

(2009) A. Ghosh et al.   JOURNAL OF NEUROSCIENCE

Use of Statins and the Risk of Parkinson???s Disease

(2008) Claudia Becker et al.   DRUG SAFETY

Statin use and the risk of Parkinson disease: a nested case control study

(2008) Ali Samii et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease

(2008) Pazit Bar-On et al.   JOURNAL OF NEUROCHEMISTRY

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

(2008) Xuemei Huang et al.   MOVEMENT DISORDERS

Statin use and the risk of Parkinson disease

(2008) A. D. Wahner et al.   NEUROLOGY

Total cholesterol and the risk of Parkinson disease

(2008) G. Hu et al.   NEUROLOGY